Search
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
Read MoreA summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
Read MoreIn PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
Read More